Inventor · disambiguated record
Laura Codarri Deak
Also filed as: CODARRI DEAK LAURA
5 granted patents·23 pending applications·16 citations·filing 2018–2025
73Inventor score
Top patents by PatentIndex Score
28 records- 0193US11285207B2Bispecific antibodies specifically binding to PD1 and LAG3HOFFMANN LA ROCHE·Filed 2018·Granted Mar 29, 2022·10 cites·32 claims
- 0291US12023368B2ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2022·Granted Jul 2, 2024·1 cites·20 claims
- 0388US11413331B2ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2018·Granted Aug 16, 2022·4 cites·30 claims
- 0485US11865082B2Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1HOFFMANN LA ROCHE·Filed 2021·Granted Jan 9, 2024·1 cites·21 claims
- 0583US2024294642A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0681US2023183349A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0778US2023143310A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0878US2025313629A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0976US2024002506A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1076US2025073308A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1171US2024216471A1Combination therapy of pd-1-targeted il-2 variant immunocytokines and antibodies against human pd-l1HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1266US2023071733A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1366US2022387586A1Bispecific antibodies specifically binding to pd1 and lag3HOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1465US2024269277A1Alternative pd1-il7v immunoconjugates for the treatment of cancerHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1564US2024425561A1New interleukin-7 immunoconjugatesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1663US2020277372A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1762US2024002546A1Combination therapy employing a pd1-lag3 bispecific antibody and a cd20 t cell bispecific antibodyHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1861US2024043535A1IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULESHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1960US2025215103A1Bispecific antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2059US2024262913A1Combination therapy of pd-1-targeted il-2 variant immunoconjugate and anti-tyrp1/anti-cd3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2158US2024327519A1Methods and compositions for treating cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 2257US2018326011A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2356US2024092856A1Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2451US2023181712A1Combination therapy with modified pbmcs and an immunoconjugateHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2551US2023192795A1ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2648US12030946B2Therapeutic and diagnostic methods for cancerHOFFMANN LA ROCHE·Filed 2019·Granted Jul 9, 2024·0 cites·6 claims
- 2748US2025361279A1New Interleukin-7 ImmunoconjugatesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2846US2020354457A1Bispecific antibodies comprising an antigen-binding site binding to lag3HOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laura Codarri Deak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →